Evidence map›Paper›PMID 28124002›Full record

ReviewHepatobiliary surgery and nutrition2016

Laparoscopic and robotic approach for hepatocellular carcinoma-state of the art.

Giovanni Battista Levi Sandri, Edoardo de Werra, Gianluca Mascianà, Marco Colasanti, Roberto Santoro, Vito D'Andrea, Giuseppe Maria Ettorre

Abstract readReview
In one paragraph

Review in Hepatobiliary surgery and nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. OncogeneAmerican journal of cancer research · 2020
    Article
  8. Recent progress in treatment of hepatocellular carcinoma.American journal of cancer research · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Laparoscopic liver resection: the current status and the future.Hepatobiliary surgery and nutrition · 2018
    Review
  14. Review
  15. Article
  16. Twenty years after: from Milan criteria to a "blended" approach.Translational gastroenterology and hepatology · 2017
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanni Battista Levi SandriDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy;; Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Edoardo de WerraDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.
Gianluca MascianàDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.
Marco ColasantiDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.
Roberto SantoroDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.
Vito D'AndreaDepartment of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Giuseppe Maria EttorreDivision of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide and the most common primary liver cancer, in over 80% of cases HCC grown on a cirrhotic liver. Laparoscopic liver resection (LLR) is now worldwide accepted considering the excellent results shown. Minimally invasive surgical approach for HCC is increasing continuously and in specialized centers seems to become the first-line approach for those patients. The aim of this review presents and discusses state of the art in the laparoscopic and robotic surgical treatment of HCC. An electronic search was performed to identify all studies dealing with HCC resected with laparoscopy or robotic approach. Indications for laparoscopic resection, robotic assisted and totally robotic resection of HCC will be doubtless increased in future years. LLR and robotic approach for HCC is safe and feasible.

Indexed as

cirrhosishepatocellular carcinoma (HCC)Laparoscopic liver resection (LLR)meldrobotic liver

Identifiers

PMID28124002
PMCPMC5218911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.